MPHMF - Callitas Health Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1328
0.0000 (0.00%)
At close: 9:30AM EDT
Stock chart is not supported by your current browser
Previous Close0.1328
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume1,082
Market Cap2.079M
Beta (3Y Monthly)-2.13
PE Ratio (TTM)N/A
EPS (TTM)-0.2220
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.62
Trade prices are not sourced from all markets
  • ACCESSWIRE21 days ago

    Callitas Health, Inc., Signs a Definitive Patent Technology Assignment Agreement to Acquire Additional Novel Cannabis Dosing Technologies

    CINCINNATI, OH / ACCESSWIRE / October 2, 2018 / Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the ''Company'' or ''Callitas'') an integrated clinical-stage pharmaceutical development, OTC consumer goods marketing and cannabis delivery development company, today announced that it signed a definitive Patent Technology Assignment Agreement with Ronald J. Thompson, MD to expand its cannabis delivery technology portfolio. The new intellectual property acquired (four separate patent applications) will cover various novel oral and ingestible products including those for orally dissolving immediate cannabis effect, sustained release cannabis effect, and a combination of both. ''Using our clinically-proven delivery technology, pharmaceutical development and intellectual property experience, we have developed and acquired multiple new patent applications that define and protect a continuum of novel advanced cannabis dosing technologies,'' said Callitas CEO, James Thompson.

  • ACCESSWIRElast month

    Callitas Health, Inc. Announces Corporate Update

    CINCINNATI, OH / ACCESSWIRE / September 18, 2018 / Callitas Health Inc. (CNSX: LILY, OTCQB: MPHMF, FSE: T3F3), (the "Company" or "Callitas"), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, today announced that it has been notified by the British Columbia Securities Commission of regulatory deficiencies for the second quarter ended June 30, 2018. A cease trade order was issued for failure to file the second quarter financial statements and report, as well as the management disccussion and analysis prior to August 30, 2018. Callitas has been in contact with the British Columbia Sercurities Commission and is working diligently to file all outstanding documents in order to fully comply with the Commission's filing requirements.

  • GlobeNewswirelast month

    Callitas Health Announces Passing of Former CEO and President Gary A. Thompson

    CINCINNATI, OH, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) announced today with great sadness, that, Gary A. Thompson, Former President and Chief Executive Officer of Callitas Health, died on September 11, 2018, after a long battle with cancer. Board Member, William Rodgers stated, “On behalf of our Board of Directors, management team and employees, we extend our deepest sympathies to the entire Thompson family.

  • Newsfile2 months ago

    InvestmentPitch Media Video Discusses Callitas Health's Consulting Agreement with BFS Innovations and Pure Leaf Group for Cannabis Delivery Technology - Video Available on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - August 24, 2018) - Callitas Health Inc. (CSE: LILY) (OTCQB: MPHMF) (FSE: T3F3) has signed a consulting agreement with BFS Innovations and Pure Leaf Group to globally launch the company's patent-pending cannabis delivery technology and proprietary business model.Cannot view this video? Visit:http://www.investmentpitch.com/video/0_pxyaxst3/Callitas-Health-Inc-CSELILY-has-signed-a-consulting-agreement-with-BFS-Innovations-and-Pure-Leaf-GroupInvestmentPitch.com has produced a "video" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Callitas" in the search box. Scott ...

  • ACCESSWIRE2 months ago

    Callitas Health, Inc. Signs Partnership Agreement with BFS Innovations and Pure Leaf Group

    CINCINNATI, OH / ACCESSWIRE / August 17, 2018 / Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "Callitas") today announced that it has signed a consulting agreement with BFS Innovations and Pure Leaf Group to launch Callitas' patent-pending cannabis delivery technology and proprietary business model globally. "This partnership allows Callitas to expand its reach and engage more groups locally and internationally," said James Thompson, President and CEO.

  • GlobeNewswire2 months ago

    Callitas Health Signs Letter of Intent with Lifestyles to Supply Unique Finished Goods for Retail Sale

    “At LifeStyles, our mission is to spark billions of joyful moments every day, regardless of gender, age, race, religion and sexuality. “We are pleased to extend our business relationship with Lifestyles,” said James Thompson, President and CEO of Callitas Health.

  • Who Are The Largest Shareholders In Callitas Health Inc (FRA:T3F3)?
    Simply Wall St.6 months ago

    Who Are The Largest Shareholders In Callitas Health Inc (FRA:T3F3)?

    I am going to take a deep dive into Callitas Health Inc’s (DB:T3F3) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure has beenRead More...

  • What Kind Of Risk Should You Expect For Callitas Health Inc (FRA:T3F3)?
    Simply Wall St.6 months ago

    What Kind Of Risk Should You Expect For Callitas Health Inc (FRA:T3F3)?

    If you are a shareholder in Callitas Health Inc’s (DB:T3F3), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...

  • Was Callitas Health Inc’s (FRA:T3F3) Earnings Growth Better Than The Industry’s?
    Simply Wall St.7 months ago

    Was Callitas Health Inc’s (FRA:T3F3) Earnings Growth Better Than The Industry’s?

    When Callitas Health Inc (DB:T3F3) released its most recent earnings update (30 September 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...

  • Is Callitas Health Inc’s (FRA:T3F3) Balance Sheet A Threat To Its Future?
    Simply Wall St.7 months ago

    Is Callitas Health Inc’s (FRA:T3F3) Balance Sheet A Threat To Its Future?

    Investors are always looking for growth in small-cap stocks like Callitas Health Inc (DB:T3F3), with a market cap of €6.24M. However, an important fact which most ignore is: how financiallyRead More...